Friend Information
Your Information

Fill out all of the required fields and click SEND to email a friend a link to this page. You can also include a custom introductory message!

Igniting Entrepreneurial Success Through Know-How and Networks

Presented By

Fusing Science, Technology & Industry Leadership

February 22-23, 2010
Raleigh, NC

HOLD THE DATE:

BIOTECH 2011
February 21-22, 2011
Raleigh Convention Center | Raleigh, NC

 


 

Conference Weekly Updates

Industry executives and thought leaders featured at CED's Biotech 2010
Leading Researcher and Four CEO's Featured as Keynote Speakers
CED Celebrates the Successes of Biotech 2010

At a time when there is the potential for tremendous change in the healthcare and biotechnology industries, the insights offered at the conference garnered a lot of attention not only from attendees but also from media outlets. Among the stories...

Life Science Event of the Southeast
Pre-registration ends Wednesday, Feb 17


CED's Biotech Conference

Fusing Science, Technology and Industry Leadership

CED's annual Biotech Conference unites the Southeast life science community to celebrate one of the biotech industry's most dynamic regions. This two-day conference includes world-class speakers, a variety of panels on industry topics and trends, and networking opportunities with life science leaders. Join industry executives, including the region's most innovative biotech entrepreneurs, major pharmaceutical companies, research leaders, policy makers and nationally prominent investors at the Southeast's premier life science event - CED's Biotech 2010 Conference.

Now in its 19th year, the Biotech 2010 conference will provide opportunities to learn about global health, personalized medicine, the current funding environment and more. Hear from renowned life science CEOs on new opportunities during changing times and gain insight from industry innovators, thought leaders and policy makers.

Co-Chairs


  Art Pappas, Pappas Ventures

John Russell, K&L Gates LLP

 


Committee Members

View Committee Members

5AM Ventures

A10 Clinical Solutions Inc.

Abingworth

Affinergy Inc.

Aisling Capital

Aldagen Inc.

Alexandria Real Estate Equities, Inc.

Alston + Bird LLP

Apposite Capital

Arboretum Ventures

ArrayXpress Inc.

Asinex

Asset Management Company

Bay Capital

BB&T

BD Technologies

Biocryst Pharmaceuticals, Inc.

BioFund Management A/S

Biogen Idec

Biotechnology Industry Organization

Blue Cross and Blue Shield of North Carolina

Brinks Hofer Gilson & Lione

Burrill & Company

Business Development Bank of Canada

Business Wire

Campbell Alliance Group, Inc.

Capnia

Care Capital

Cato BioVentures

CEDRA Corporation

CLINIPACE

ClinPharm Consulting

CMEA Capital

Cognosci Inc.

CR Intrinsic Investors

CRB

CTMG Inc.

Domain Associates

Duke Medicine

Duke University Medical Center

Duke University's Fuqua School of Business, Health Sector Management

Edge Office

Eli Lilly and Company

Endacea Inc.

Ernst & Young

Flad Architects

Forma Life Science Marketing

Forward Ventures

GE Equity - Healthymagination Fund

GeneChem

Genentech, Inc.

Genesys Capital

Genomic Health

Georgia Venture Partners

Gilero LLC

GlaxoSmithKline

Golden Pine Ventures

Grant Thornton LLP

H.I.G. BioVentures

Harbert Venture Partners

Harris & Harris Group, Inc.

Hatteras Venture Partners

Health Decisions, Inc.

Hoffmann-La Roche, Inc.

Hughes Pittman & Gupton LLP

Humana

Hutchison Law Group

IDEA Fund Partners

Inception Micro Angel Fund - Charlotte

IndiPharm

Inspire Pharmaceuticals Inc.

Intersouth Partners

K&L Gates

Laser Image Corporate Printing

Lazard Frères & Co. LLC

Lazard's Healthcare Group

Lenovo

Liquidia Technologies, Inc.

Longitude Capital

Lumira Capital Corp.

Lux Capital

Maverick Technologies

Max Neeman International

Max Neeman International Inc.

McKenna Long & Aldridge LLP

MedImmune Ventures

Merck & Co. Inc.

MMI Public Relations

MP Healthcare Venture Management, Inc.

MPI Research

NEA

NeoMed, Inc.

NGN Capital

North Carolina Department of Health and Human Services

Novartis Option Fund

OrbiMed Advisors LLC

Oxford Bioscience Partners

Pappas Ventures

Parker Poe Adams & Bernstein LLP

Passé Intellectual Property, LLC

Personalized Medicine Partners, LLC

Pharmaceutical Product Development, Inc. (PPD)

PharmaDirections Inc.

PhRMA

PHYSIC Ventures, LLC

Poyner Spruill LLP

Precision BioSciences Inc.

ProQuest Investments

PSI

Quaker BioVentures

Quintiles Transnational Corp.

Rho Inc.

Robinson, Bradshaw & Hinson, P.A.

RTI International

SalesForce4Hire

Sanderling Ventures

Sanderling Ventures

SCYNEXIS, Inc.

ShareFile

Skyline Ventures

Smith, Anderson, Blount, Dorsett, Mitchell & Jernigan, L.L.P.

SRA International, Inc.

STATKING Consulting, Inc.

SV Life Sciences

Synereca Pharmaceuticals Inc.

Syngenta Ventures

Takeda Research Investment

Talecris Biotherapeutics

Targacept, Inc.

Technology Partnership of Nagoya University Inc.

Teva Innovative Ventures

The Aurora Funds

The Hamner Institutes for Health Sciences

TPG Biotech

Trana Discovery Inc.

Triangle BioSystems Int’l

Triangle Business Journal

Triangle Global Health Consortium

Tri-Bio Ventures LLC

UNC Health Care

Valeant Pharmaceuticals International

Venture Investors LLC

Vivo Ventures

Wake County Economic Development

WakeMed

Warburg Pincus LLC

Womble Carlyle Sandridge & Rice PLLC

Wyrick Robbins Yates Ponton LLP

Yukon Medical

 

© Copyright 1996-2009 Council for Entrepreneurial Development (CED). All rights reserved.